Evotec AG (NASDAQ:EVTCY)

BRIEF

published on 11/06/2024 at 07:05, 1 year 2 months ago

Evotec SE Reports Strategic Progress and Revenue Growth Amid Challenges

Strategic Partnerships 2024 Forecasts Biologics Growth Evotec Financial Results Priority Reset Initiative
PRESS RELEASE

published on 11/06/2024 at 07:00, 1 year 2 months ago

Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Evotec SE reports 9M 2024 results with strategic progress amid challenging market conditions. New partnerships and operational milestones achieved

Financial Results Evotec SE Partnerships 9M 2024 Operational Milestones
BRIEF

published on 11/05/2024 at 07:34, 1 year 2 months ago

Evotec Divests API Manufacturing Facility to Monacum Partners

Evotec Strategic Divestment Monacum Partners API Manufacturing Priority Reset
PRESS RELEASE

published on 11/05/2024 at 07:29, 1 year 2 months ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Evotec announces sale of chemical API manufacturing facility to Monacum Partners as part of strategic optimization efforts to focus on key growth areas. Evotec DS in Halle/Westphalia to become DAPIN GmbH under new ownership

Sale Strategic Optimization Evotec Monacum Partners API Manufacturing
BRIEF

published on 10/30/2024 at 08:15, 1 year 3 months ago

Evotec SE to Release Nine-Month 2024 Financial Results

Financial Results Conference Call Evotec SE Strategic Review Therapeutics Development
PRESS RELEASE

published on 10/30/2024 at 08:10, 1 year 3 months ago

Evotec SE to announce results for the first nine months 2024 on 06 November 2024
Evotec SE to announce financial results for the first nine months of 2024 on 06 November 2024, including conference call discussing strategic review process

Financial Results Conference Call Evotec SE Life Science Strategic Review
BRIEF

published on 10/23/2024 at 07:34, 1 year 3 months ago

Evotec and Bristol Myers Squibb Strengthen Proteomics Collaboration

Drug Discovery Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership Evotec Collaboration
PRESS RELEASE

published on 10/23/2024 at 07:29, 1 year 3 months ago

Evotec and Bristol Myers Squibb expand proteomics partnership
Evotec SE and Bristol Myers Squibb expand proteomics partnership, advancing molecular glue degraders beyond oncology. Evotec receives US$50m payment

Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership
BRIEF

published on 09/26/2024 at 07:35, 1 year 4 months ago

Evotec and Novo Nordisk Enter Partnership for Next-Generation Cell Therapies

Partnership Cell Therapy Stem Cells Evotec Novo Nordisk
PRESS RELEASE

published on 09/26/2024 at 07:30, 1 year 4 months ago

Evotec and Novo Nordisk enter into technology development partnership to support next-generation cell therapies
Evotec and Novo Nordisk partner for next-gen cell therapies. Novo Nordisk funds Evotec for tech development in stem cell-based therapies, aiming for clinical and commercial success

Partnership Evotec Technology Development Novo Nordisk Cell Therapies

Published on 01/30/2026 at 14:00, 5 hours 34 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 10 hours 59 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 11 hours 34 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 17 hours 19 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 19 hours 34 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 19:13, 21 minutes ago

Total Voting Rights
Published on 01/30/2026 at 18:31, 1 hour 3 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 18:30, 1 hour 3 minutes ago

HOL-Holdings in Company
Published on 01/30/2026 at 18:23, 1 hour 11 minutes ago

TVR-Total Voting Rights
Published on 01/30/2026 at 18:17, 1 hour 16 minutes ago

POS-Transaction in Own Shares

View all EQS

Published on 01/30/2026 at 17:45, 1 hour 49 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 11 hours 34 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 1 hour ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 1 hour ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News